This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07158/identifier/pdb/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/drugbank/drug/DB07158/identifier/pubchem-compound/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07158/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/drug/DB07158/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n5http://linked.opendata.cz/resource/drugbank/drug/DB07158/identifier/chemspider/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n7http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07158
rdf:type
n7:Drug
n7:group
experimental
owl:sameAs
n10:DB07158 n11:DB07158
dcterms:title
5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE
adms:identifier
n4:708346 n5:617662 n6:DB07158 n13:99443629 n14:582
n7:IUPAC-Name
n8:271B4FAF-363D-11E5-9242-09173F13E4C5
n7:InChI
n8:271B4FB5-363D-11E5-9242-09173F13E4C5
n7:Molecular-Formula
n8:271B4FB4-363D-11E5-9242-09173F13E4C5
n7:Molecular-Weight
n8:271B4FB1-363D-11E5-9242-09173F13E4C5
n7:Monoisotopic-Weight
n8:271B4FB2-363D-11E5-9242-09173F13E4C5
n7:SMILES
n8:271B4FB3-363D-11E5-9242-09173F13E4C5
n7:Water-Solubility
n8:271B4FAD-363D-11E5-9242-09173F13E4C5
n7:logP
n8:271B4FAB-363D-11E5-9242-09173F13E4C5 n8:271B4FAE-363D-11E5-9242-09173F13E4C5
n7:logS
n8:271B4FAC-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Acceptor-Count
n8:271B4FBB-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Donor-Count
n8:271B4FBC-363D-11E5-9242-09173F13E4C5
n7:InChIKey
n8:271B4FB6-363D-11E5-9242-09173F13E4C5
n7:Polar-Surface-Area--PSA-
n8:271B4FB7-363D-11E5-9242-09173F13E4C5
n7:Polarizability
n8:271B4FB9-363D-11E5-9242-09173F13E4C5
n7:Refractivity
n8:271B4FB8-363D-11E5-9242-09173F13E4C5
n7:Rotatable-Bond-Count
n8:271B4FBA-363D-11E5-9242-09173F13E4C5
n7:Bioavailability
n8:271B4FC1-363D-11E5-9242-09173F13E4C5
n7:Ghose-Filter
n8:271B4FC3-363D-11E5-9242-09173F13E4C5
n7:MDDR-Like-Rule
n8:271B4FC4-363D-11E5-9242-09173F13E4C5
n7:Number-of-Rings
n8:271B4FC0-363D-11E5-9242-09173F13E4C5
n7:Physiological-Charge
n8:271B4FBF-363D-11E5-9242-09173F13E4C5
n7:Rule-of-Five
n8:271B4FC2-363D-11E5-9242-09173F13E4C5
n7:Traditional-IUPAC-Name
n8:271B4FB0-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-acidic-
n8:271B4FBD-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-basic-
n8:271B4FBE-363D-11E5-9242-09173F13E4C5